You are here

Anatomy of a Market Leader

Anatomy of a Market Leader

Many companies are pursuing biosimilars development programs, but there's a lot more than that to creating a thriving biosimilars business. Developing high-quality and reliable biosimilars requires demonstrated manufacturing capabilities, extensive resources, and expertise. Pfizer already possesses the anatomy of a market leader in biosimilars:

  • Expertise with biologics, regulatory agencies, drug delivery, and commercialization
  • Postmarketing, long-term data, and pharmacovigilance tracking experience
  • Insights about physicians, patients, and payers
  • Manufacturing capabilities that deliver on consistency, quality, and reliability
  • Physician and patient offerings, and education
  • Expertise in contracting and distribution

 

Biosimilars Clinical Trials

The following compounds are being investigated by Pfizer Biosimilars

PF-05280014

PF-05280586

PF-06410293

PF-06438179

PF-06439535